Virus de la hepatitis C en pacientes de una unidad de hemodiálisis

Valtuille, Rodolfo; Fernández, José Luis; del Pino, Noemí; Lef, Leonardo; Berridi, José; Moretto, Héctor; Rendo, Pablo.
Rev. nefrol. diálisis transpl ; (42): 9-22, abr. 1997. tab, graf
Artículo en Español | BINACIS | ID: bin-123873

Documentos relacionados

  1. Finally, safe and effective treatment options for hepatitis C in hemodialysis patients.
  2. International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.
  3. Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study.
  4. The authors reply.
  5. Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
  6. Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia.
  7. How Frequently Should We Screen for Hepatitis C in US Hemodialysis Centers? Evaluating the Cost-Effectiveness of Different Strategies.
  8. Patient-centered outreach treatment toward micro-elimination of hepatitis C virus infection in hemodialysis patients.
  9. New Insights Into Optimal Timing of Hepatitis C Virus Treatment for Dialysis Patients Waitlisted for Kidney Transplant.
  10. Review: Occult hepatitis C virus infection: still remains a controversy.